Risk of Drug-Induced Liver Injury From Tumor Necrosis Factor Antagonists-Reference-Cited by-同舟云学术

Risk of Drug-Induced Liver Injury From Tumor Necrosis Factor Antagonists

Published:2015-03 Issue:3 Volume:13 Page:602-608
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Björnsson Einar S.,Gunnarsson Baldvin I.,Gröndal Gerdur,Jonasson Jon G.,Einarsdottir Rannveig,Ludviksson Björn R.,Gudbjörnsson Björn,Olafsson Sigurdur

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference24 articles.

1. Infliximab-associated reversible cholestatic liver disease;Menghini;Mayo Clin Proc,2001

2. Hepatitis with interface inflammation and IgG, IgM, and IgA anti-double-stranded DNA antibodies following infliximab therapy: comment on the article by Charles, et al;Saleem;Arthritis Rheum,2001

3. Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis;Germano;Ann Rheum Dis,2005

4. Serious liver disease induced by infliximab;Tobon;Clin Rheumatol,2007

5. A case of autoimmune hepatitis exacerbated by the administration of etanercept in the patient with rheumatoid arthritis;Harada;Clin Rheumatol,2008

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Certolizumab-Induced Liver Injury in Ankylosing Spondylitis: A Case Report and Causality Assessment;Cureus;2024-08-10

2. Infliximab in steroid-refractory immune-related hepatitis does not demonstrate hepatotoxicity and may shorten time on steroids;Journal for ImmunoTherapy of Cancer;2024-07

3. Inflammatory Bowel Disease Therapies and Acute Liver Injury;Toxics;2024-06-08

4. Challenges and perspectives of liver tissue engineering: From cell therapy to bioprinting;International Journal of Bioprinting;2024-03-29

5. Autoimmune Hepatitis: A Diagnostic and Therapeutic Overview;Diagnostics;2024-02-09